Skip to main content
. 2018 Feb 26;15(5):6555–6561. doi: 10.3892/ol.2018.8116

Table I.

Histopathological factors assessed in study population.

Histopathological factors Subjects with PNI (n=18) Subjects without PNI (n=192) P-valuea
Age, yearsb 47.06 (±7.78) 44.22 (±8.56) 0.908
FIGO stage, n (%) 0.286
  Ia2 0 3 (1.56)
  Ib1 5 (27.78) 80 (41.67)
  Ib2 10 (55.56) 64 (33.33)
  IIa1 0 17 (8.85)
  IIa2 3 (16.67) 28 (14.58)
Pathology, n (%) 0.352
  SCC 16 (88.89) 157 (81.77)
  Adeno/adenosquamous carcinoma 2 (11.11) 35 (18.23)
Histological grade, n (%) 0.371
  Well differentiated 2 (11.11) 30 (15.62)
  Moderate differentiation 6 (33.33) 88 (45.83)
  Poor differentiation 10 (55.56) 74 (38.54)
Tumor size 0.045
  ≤4 cm 5 (27.78) 99 (51.56)
  >4 cm 13 (72.22) 93 (48.44)
Depth of invasion <0.001
  <2/3 2 (11.11) 111 (57.81)
  ≥2/3 16 (88.89) 81 (42.19)
Parametrial invasion <0.001
  Present 8 2
  Absent 10 190
LVSI 0.005
  Present 7 22
  Absent 11 170
Lymph nodes metastases 0.001
  Positive 10 34
  Negative 8 158
Positive vaginal margin 0.518
  Positive 1 7
  Negative 17 185
a

Comparison between patients with and without PNI.

b

Data are presented as the mean ± standard deviation. PNI, perineural invasion; SCC, squamous cell carcinoma; LVSI, lymphovascular space invasion; FIGO, International Federation of Gynecology and Obstetrics.